Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the LiteratureMedicine Published on 2020-04-242022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] administration of methylprednisolone ARDS association Chinese clinical outcomes conducted coronavirus Corticosteroid Corticosteroids COVID-19 database detrimental diagnosis of COVID-19 Effectiveness form forms glucocorticoid Health literature lower mortality Methylprednisolone nine outcomes participant patients with COVID-19 Pneumonia reduced reported review risk of death SARS-CoV-2 significantly Stage Support therapy use of corticosteroid [DOI] 10.3389/fmed.2020.00170 PMC 바로가기 [Article Type] Medicine
The daily impact of COVID-19 in gastroenterologyReview Articles Published on 2020-04-112022-10-29 Journal: United European gastroenterology journal [Category] COVID-19, SARS, [키워드] absence Cluster Contact Contamination coronavirus Corticosteroid COVID-19 dose effective endoscopy Epidemic Epidemiology evidenced Evolution Factors gastroenterology General population healthcare IBD immunology immunomodulatory immunosuppressive increased risk Inflammatory bowel disease new strain pandemic Patient patients with pneumonia potential risk provided recommendation reduce mortality reduced Research SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 transmission susceptibility suspected patient the disease Transmission Treatment Vaccines virus spread Wuhan, China [DOI] 10.1177/2050640620920157 PMC 바로가기 [Article Type] Review Articles
A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19)Infectious Disease Published on 2020-04-062022-10-31 Journal: Cureus [Category] COVID-19, [키워드] ACE ACE2 Angiotensin-converting enzyme ARDS Basic science Biochemistry can be used candidate CDC center Chloroquine clinical Clinical course Clinical practice clinical trial Comprehensive Control Coronavirus disease 2019 Corticosteroid COVID-19 COVID19 described diagnostic discharge disease course epidemiological evaluate evaluated Evolution experiment explain Factor Frequency global pandemic H1N1 hindrance hospital ibuprofen Infection information inhibitors limitation literature literature review LOPINAVIR AND RITONAVIR management manuscript media MERS Micronutrient mRNA-1273 vaccine multiple parameter nonsteroidal anti-inflammatory drug NSAIDS outbreak pandemic Phylogeny presentation Prophylaxis Public health interventions remdesivir (GS-5734) review risk factor SARS-CoV-2 self-quarantine severe acute respiratory infection Spread statistical Stratification Symptom the SARS-CoV-2 virus the WHO therapy Treatment viral genome virion Vitamin C [DOI] 10.7759/cureus.7560 PMC 바로가기 [Article Type] Infectious Disease
COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?Short Communication Published on 2020-03-302022-10-31 Journal: ecancermedicalscience [Category] COVID-19, [키워드] acute phase article clinician Corticosteroid Corticosteroids COVID-19 COVID-19 patients Evidence exacerbate identify Infection information non-steroidal anti-inflammatory drug Non-steroidal anti-inflammatory drugs NSAID NSAIDS pandemic Patient patients SARS-CoV-2 Symptom treat Treatment utilised viral infection World Health Organisation [DOI] 10.3332/ecancer.2020.1023 PMC 바로가기 [Article Type] Short Communication
COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trialDEXamethasone(CoDEX)으로 치료된 COVID-19 관련 ARDS: 무작위 시험에 대한 연구 설계 및 근거Original Article Published on 2020-01-012022-08-13 Journal: Revista Brasileira de Terapia Intensiva [Category] 임상, [키워드] 350 patient 350 patients 48 hour 48 hours 6-level ordinal scale acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration Adrenal cortex hormones Adult patients all-cause mortality rate all-cause mortality rates assessment Berlin criteria caused clinical status clinical trial Control control group Controlled trial coronavirus coronavirus disease Coronavirus disease 2019 coronavirus disease 2019 - COVID-19 Corticosteroid Corticosteroides Corticosteroids COVID-19 COVID-19-associated ARDS Cuidados críticos days alive defined develop Dexametasona Dexamethasone dexamethasone 10mg IV dexamethasone 20mg intravenous early-onset Effectiveness Eligible patients evaluate evaluated failure followed by group hospitalized patient hospitalized patients Infection intensive care intervention group intravenous Invasive mechanical ventilation less mechanical ventilation mechanical ventilation duration moderate mortality rates multicenter Non-COVID-19 non-COVID-19 acute respiratory distress syndrome objective occur once daily Open-label Ordinal Scale outcome pandemic Patient patients with moderate Pneumonia Pragmatic Primary outcome randomization Randomized randomized trial Randomly receive respiratory respiratory compromise respiratory distress Respiratory distress syndrome Respiratory distress syndrome, adult Síndrome do desconforto respiratório do adulto SARS-CoV-2 SARS-COV-2 infection score secondary Secondary outcomes severe acute respiratory syndrome Coronavirus Spread standard treatment stratified Study design syndrome treated Trial unit discharge ventilator-free day Ventilator-free days Viral Viral pneumonia [DOI] 10.5935/0103-507X.20200063 PMC 바로가기 [Article Type] Original Article
Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposureArticle Published on 2020-01-012023-06-11 Journal: Journal of hepatology [Category] B형 간염, [키워드] Antiviral treatment Corticosteroid HBV Icteric flare immunosuppressants Occult hepatitis [DOI] 10.1016/j.jhep.2019.08.023
Plasmapheresis with corticosteroids and antiviral: a life-saving treatment for severe cases of Covid 19Case Report Published on 2020-01-012022-10-31 Journal: Caspian Journal of Internal Medicine [Category] COVID-19, [키워드] added administration Antiviral antiviral treatments Cardiopulmonary Corticosteroid corticosteroid therapy COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 patients Critical critical condition Critically ill Cytokine storm Cytokines Dexamethasone diagnosis of COVID-19 discharged dose effective Endotracheal intubation general condition Hospitalization ICU immune system injected interferon Loss of consciousness modulated modulation Patient Plasmapheresis regimen released SARS-CoV-2 Severe case subcutaneously suffered the patient Therapeutic plasma exchange transferred Treatment virus was performed [DOI] 10.22088/cjim.11.0.572 PMC 바로가기 [Article Type] Case Report
Corticosteroid improves liver function but does not curb the clinical progression of hepatitis B virus-related acute-on-chronic pre-liver failureRandomized Controlled Trial Published on 2019-11-012023-06-16 Journal: Expert review of gastroenterology & hepatology [Category] B형 간염, [키워드] Acute-on-chronic Corticosteroid Hepatitis B virus pre liver failure Prognosis [DOI] 10.1080/17474124.2019.1688143 [Article Type] Randomized Controlled Trial
Increased risk of opportunistic infection in early rheumatoid arthritis조기 류마티스 관절염에서 기회 감염의 위험 증가Article Published on 2019-07-012023-06-01 Journal: International journal of rheumatic diseases [Category] 대상포진, 두창, 수두, 홍역, [키워드] Corticosteroid disease-modifying antirheumatic drugs (biologic) opportunistic Infections rheumatoid arthritis [DOI] 10.1111/1756-185X.13585
Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis BArticle Published on 2019-02-012023-06-19 Journal: Liver international : official journal of the Inte [Category] B형 간염, [키워드] Antiviral treatment Chronic Hepatitis B Corticosteroid hepatitis flare Icteric flare immunosuppressants immunosuppressive therapy [DOI] 10.1111/liv.13953